Plaque psoriasis is the most common form of psoriasis, a chronic, relapsing autoimmune skin disease characterized by red, thick patches of skin with silvery white scales.
The global Plaque Psoriasis Treatment Medications market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.

The US & Canada market for Plaque Psoriasis Treatment Medications is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The China market for Plaque Psoriasis Treatment Medications is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The Europe market for Plaque Psoriasis Treatment Medications is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key manufacturers of Plaque Psoriasis Treatment Medications include Amgen, Allergan, Dermira, Eli Lilly, Novartis, Merck, Johnson & Johnson, Pfizer, AstraZeneca, AbbVie, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Plaque Psoriasis Treatment Medications, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Plaque Psoriasis Treatment Medications, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Plaque Psoriasis Treatment Medications, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Plaque Psoriasis Treatment Medications sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Plaque Psoriasis Treatment Medications market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Plaque Psoriasis Treatment Medications sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Amgen, Allergan, Dermira, Eli Lilly, Novartis, Merck, Johnson & Johnson, Pfizer, AstraZeneca, AbbVie, etc.
Market Segmentation
By Company
Amgen
Allergan
Dermira
Eli Lilly
Novartis
Merck
Johnson & Johnson
Pfizer
AstraZeneca
AbbVie
LEO Pharma
Biogen
Galectin Therapeutics
Cellceutix
Bayer
Organon
UCB
Segment by Type
Biologics
Small Molecule Drugs
Non-biologic Drugs
Segment by Application
Hospital
Clinic
Other
Segment by region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Australia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Plaque Psoriasis Treatment Medications in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Plaque Psoriasis Treatment Medications manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Plaque Psoriasis Treatment Medications sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

1 Study Coverage 1.1 Plaque Psoriasis Treatment Medications Product Introduction 1.2 Market by Type 1.2.1 Global Plaque Psoriasis Treatment Medications Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 1.2.2 Biologics 1.2.3 Small Molecule Drugs 1.2.4 Non-biologic Drugs 1.3 Market by Application 1.3.1 Global Plaque Psoriasis Treatment Medications Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Other 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Executive Summary 2.1 Global Plaque Psoriasis Treatment Medications Revenue Estimates and Forecasts 2019-2030 2.2 Global Plaque Psoriasis Treatment Medications Revenue by Region 2.2.1 Global Plaque Psoriasis Treatment Medications Revenue by Region: 2019 VS 2023 VS 2030 2.2.2 Global Plaque Psoriasis Treatment Medications Revenue by Region (2019-2024) 2.2.3 Global Plaque Psoriasis Treatment Medications Revenue by Region (2025-2030) 2.2.4 Global Plaque Psoriasis Treatment Medications Revenue Market Share by Region (2019-2030) 2.3 Global Plaque Psoriasis Treatment Medications Sales Estimates and Forecasts 2019-2030 2.4 Global Plaque Psoriasis Treatment Medications Sales by Region 2.4.1 Global Plaque Psoriasis Treatment Medications Sales by Region: 2019 VS 2023 VS 2030 2.4.2 Global Plaque Psoriasis Treatment Medications Sales by Region (2019-2024) 2.4.3 Global Plaque Psoriasis Treatment Medications Sales by Region (2025-2030) 2.4.4 Global Plaque Psoriasis Treatment Medications Sales Market Share by Region (2019-2030) 2.5 US & Canada 2.6 Europe 2.7 China 2.8 Asia (excluding China) 2.9 Middle East, Africa and Latin America 3 Competition by Manufacturers 3.1 Global Plaque Psoriasis Treatment Medications Sales by Manufacturers 3.1.1 Global Plaque Psoriasis Treatment Medications Sales by Manufacturers (2019-2024) 3.1.2 Global Plaque Psoriasis Treatment Medications Sales Market Share by Manufacturers (2019-2024) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Plaque Psoriasis Treatment Medications in 2023 3.2 Global Plaque Psoriasis Treatment Medications Revenue by Manufacturers 3.2.1 Global Plaque Psoriasis Treatment Medications Revenue by Manufacturers (2019-2024) 3.2.2 Global Plaque Psoriasis Treatment Medications Revenue Market Share by Manufacturers (2019-2024) 3.2.3 Global Top 10 and Top 5 Companies by Plaque Psoriasis Treatment Medications Revenue in 2023 3.3 Global Key Players of Plaque Psoriasis Treatment Medications, Industry Ranking, 2021 VS 2022 3.4 Global Plaque Psoriasis Treatment Medications Sales Price by Manufacturers (2019-2024) 3.5 Analysis of Competitive Landscape 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.5.2 Global Plaque Psoriasis Treatment Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.6 Global Key Manufacturers of Plaque Psoriasis Treatment Medications, Manufacturing Base Distribution and Headquarters 3.7 Global Key Manufacturers of Plaque Psoriasis Treatment Medications, Product Offered and Application 3.8 Global Key Manufacturers of Plaque Psoriasis Treatment Medications, Date of Enter into This Industry 3.9 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Plaque Psoriasis Treatment Medications Sales by Type 4.1.1 Global Plaque Psoriasis Treatment Medications Historical Sales by Type (2019-2024) 4.1.2 Global Plaque Psoriasis Treatment Medications Forecasted Sales by Type (2025-2030) 4.1.3 Global Plaque Psoriasis Treatment Medications Sales Market Share by Type (2019-2030) 4.2 Global Plaque Psoriasis Treatment Medications Revenue by Type 4.2.1 Global Plaque Psoriasis Treatment Medications Historical Revenue by Type (2019-2024) 4.2.2 Global Plaque Psoriasis Treatment Medications Forecasted Revenue by Type (2025-2030) 4.2.3 Global Plaque Psoriasis Treatment Medications Revenue Market Share by Type (2019-2030) 4.3 Global Plaque Psoriasis Treatment Medications Price by Type 4.3.1 Global Plaque Psoriasis Treatment Medications Price by Type (2019-2024) 4.3.2 Global Plaque Psoriasis Treatment Medications Price Forecast by Type (2025-2030) 5 Market Size by Application 5.1 Global Plaque Psoriasis Treatment Medications Sales by Application 5.1.1 Global Plaque Psoriasis Treatment Medications Historical Sales by Application (2019-2024) 5.1.2 Global Plaque Psoriasis Treatment Medications Forecasted Sales by Application (2025-2030) 5.1.3 Global Plaque Psoriasis Treatment Medications Sales Market Share by Application (2019-2030) 5.2 Global Plaque Psoriasis Treatment Medications Revenue by Application 5.2.1 Global Plaque Psoriasis Treatment Medications Historical Revenue by Application (2019-2024) 5.2.2 Global Plaque Psoriasis Treatment Medications Forecasted Revenue by Application (2025-2030) 5.2.3 Global Plaque Psoriasis Treatment Medications Revenue Market Share by Application (2019-2030) 5.3 Global Plaque Psoriasis Treatment Medications Price by Application 5.3.1 Global Plaque Psoriasis Treatment Medications Price by Application (2019-2024) 5.3.2 Global Plaque Psoriasis Treatment Medications Price Forecast by Application (2025-2030) 6 US & Canada 6.1 US & Canada Plaque Psoriasis Treatment Medications Market Size by Type 6.1.1 US & Canada Plaque Psoriasis Treatment Medications Sales by Type (2019-2030) 6.1.2 US & Canada Plaque Psoriasis Treatment Medications Revenue by Type (2019-2030) 6.2 US & Canada Plaque Psoriasis Treatment Medications Market Size by Application 6.2.1 US & Canada Plaque Psoriasis Treatment Medications Sales by Application (2019-2030) 6.2.2 US & Canada Plaque Psoriasis Treatment Medications Revenue by Application (2019-2030) 6.3 US & Canada Plaque Psoriasis Treatment Medications Market Size by Country 6.3.1 US & Canada Plaque Psoriasis Treatment Medications Revenue by Country: 2019 VS 2023 VS 2030 6.3.2 US & Canada Plaque Psoriasis Treatment Medications Revenue by Country (2019-2030) 6.3.3 US & Canada Plaque Psoriasis Treatment Medications Sales by Country (2019-2030) 6.3.4 US 6.3.5 Canada 7 Europe 7.1 Europe Plaque Psoriasis Treatment Medications Market Size by Type 7.1.1 Europe Plaque Psoriasis Treatment Medications Sales by Type (2019-2030) 7.1.2 Europe Plaque Psoriasis Treatment Medications Revenue by Type (2019-2030) 7.2 Europe Plaque Psoriasis Treatment Medications Market Size by Application 7.2.1 Europe Plaque Psoriasis Treatment Medications Sales by Application (2019-2030) 7.2.2 Europe Plaque Psoriasis Treatment Medications Revenue by Application (2019-2030) 7.3 Europe Plaque Psoriasis Treatment Medications Market Size by Country 7.3.1 Europe Plaque Psoriasis Treatment Medications Revenue by Country: 2019 VS 2023 VS 2030 7.3.2 Europe Plaque Psoriasis Treatment Medications Revenue by Country (2019-2030) 7.3.3 Europe Plaque Psoriasis Treatment Medications Sales by Country (2019-2030) 7.3.4 Germany 7.3.5 France 7.3.6 U.K. 7.3.7 Italy 7.3.8 Russia 8 China 8.1 China Plaque Psoriasis Treatment Medications Market Size by Type 8.1.1 China Plaque Psoriasis Treatment Medications Sales by Type (2019-2030) 8.1.2 China Plaque Psoriasis Treatment Medications Revenue by Type (2019-2030) 8.2 China Plaque Psoriasis Treatment Medications Market Size by Application 8.2.1 China Plaque Psoriasis Treatment Medications Sales by Application (2019-2030) 8.2.2 China Plaque Psoriasis Treatment Medications Revenue by Application (2019-2030) 9 Asia (excluding China) 9.1 Asia Plaque Psoriasis Treatment Medications Market Size by Type 9.1.1 Asia Plaque Psoriasis Treatment Medications Sales by Type (2019-2030) 9.1.2 Asia Plaque Psoriasis Treatment Medications Revenue by Type (2019-2030) 9.2 Asia Plaque Psoriasis Treatment Medications Market Size by Application 9.2.1 Asia Plaque Psoriasis Treatment Medications Sales by Application (2019-2030) 9.2.2 Asia Plaque Psoriasis Treatment Medications Revenue by Application (2019-2030) 9.3 Asia Plaque Psoriasis Treatment Medications Market Size by Region 9.3.1 Asia Plaque Psoriasis Treatment Medications Revenue by Region: 2019 VS 2023 VS 2030 9.3.2 Asia Plaque Psoriasis Treatment Medications Revenue by Region (2019-2030) 9.3.3 Asia Plaque Psoriasis Treatment Medications Sales by Region (2019-2030) 9.3.4 Japan 9.3.5 South Korea 9.3.6 China Taiwan 9.3.7 Southeast Asia 9.3.8 India 9.3.9 Australia 10 Middle East, Africa and Latin America 10.1 Middle East, Africa and Latin America Plaque Psoriasis Treatment Medications Market Size by Type 10.1.1 Middle East, Africa and Latin America Plaque Psoriasis Treatment Medications Sales by Type (2019-2030) 10.1.2 Middle East, Africa and Latin America Plaque Psoriasis Treatment Medications Revenue by Type (2019-2030) 10.2 Middle East, Africa and Latin America Plaque Psoriasis Treatment Medications Market Size by Application 10.2.1 Middle East, Africa and Latin America Plaque Psoriasis Treatment Medications Sales by Application (2019-2030) 10.2.2 Middle East, Africa and Latin America Plaque Psoriasis Treatment Medications Revenue by Application (2019-2030) 10.3 Middle East, Africa and Latin America Plaque Psoriasis Treatment Medications Market Size by Country 10.3.1 Middle East, Africa and Latin America Plaque Psoriasis Treatment Medications Revenue by Country: 2019 VS 2023 VS 2030 10.3.2 Middle East, Africa and Latin America Plaque Psoriasis Treatment Medications Revenue by Country (2019-2030) 10.3.3 Middle East, Africa and Latin America Plaque Psoriasis Treatment Medications Sales by Country (2019-2030) 10.3.4 Brazil 10.3.5 Mexico 10.3.6 Turkey 10.3.7 Israel 10.3.8 GCC Countries 11 Corporate Profile 11.1 Amgen 11.1.1 Amgen Company Information 11.1.2 Amgen Overview 11.1.3 Amgen Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2019-2024) 11.1.4 Amgen Plaque Psoriasis Treatment Medications Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Amgen Recent Developments 11.2 Allergan 11.2.1 Allergan Company Information 11.2.2 Allergan Overview 11.2.3 Allergan Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2019-2024) 11.2.4 Allergan Plaque Psoriasis Treatment Medications Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Allergan Recent Developments 11.3 Dermira 11.3.1 Dermira Company Information 11.3.2 Dermira Overview 11.3.3 Dermira Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2019-2024) 11.3.4 Dermira Plaque Psoriasis Treatment Medications Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Dermira Recent Developments 11.4 Eli Lilly 11.4.1 Eli Lilly Company Information 11.4.2 Eli Lilly Overview 11.4.3 Eli Lilly Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2019-2024) 11.4.4 Eli Lilly Plaque Psoriasis Treatment Medications Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Eli Lilly Recent Developments 11.5 Novartis 11.5.1 Novartis Company Information 11.5.2 Novartis Overview 11.5.3 Novartis Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2019-2024) 11.5.4 Novartis Plaque Psoriasis Treatment Medications Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Novartis Recent Developments 11.6 Merck 11.6.1 Merck Company Information 11.6.2 Merck Overview 11.6.3 Merck Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2019-2024) 11.6.4 Merck Plaque Psoriasis Treatment Medications Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Merck Recent Developments 11.7 Johnson & Johnson 11.7.1 Johnson & Johnson Company Information 11.7.2 Johnson & Johnson Overview 11.7.3 Johnson & Johnson Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2019-2024) 11.7.4 Johnson & Johnson Plaque Psoriasis Treatment Medications Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 Johnson & Johnson Recent Developments 11.8 Pfizer 11.8.1 Pfizer Company Information 11.8.2 Pfizer Overview 11.8.3 Pfizer Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2019-2024) 11.8.4 Pfizer Plaque Psoriasis Treatment Medications Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 Pfizer Recent Developments 11.9 AstraZeneca 11.9.1 AstraZeneca Company Information 11.9.2 AstraZeneca Overview 11.9.3 AstraZeneca Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2019-2024) 11.9.4 AstraZeneca Plaque Psoriasis Treatment Medications Product Model Numbers, Pictures, Descriptions and Specifications 11.9.5 AstraZeneca Recent Developments 11.10 AbbVie 11.10.1 AbbVie Company Information 11.10.2 AbbVie Overview 11.10.3 AbbVie Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2019-2024) 11.10.4 AbbVie Plaque Psoriasis Treatment Medications Product Model Numbers, Pictures, Descriptions and Specifications 11.10.5 AbbVie Recent Developments 11.11 LEO Pharma 11.11.1 LEO Pharma Company Information 11.11.2 LEO Pharma Overview 11.11.3 LEO Pharma Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2019-2024) 11.11.4 LEO Pharma Plaque Psoriasis Treatment Medications Product Model Numbers, Pictures, Descriptions and Specifications 11.11.5 LEO Pharma Recent Developments 11.12 Biogen 11.12.1 Biogen Company Information 11.12.2 Biogen Overview 11.12.3 Biogen Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2019-2024) 11.12.4 Biogen Plaque Psoriasis Treatment Medications Product Model Numbers, Pictures, Descriptions and Specifications 11.12.5 Biogen Recent Developments 11.13 Galectin Therapeutics 11.13.1 Galectin Therapeutics Company Information 11.13.2 Galectin Therapeutics Overview 11.13.3 Galectin Therapeutics Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2019-2024) 11.13.4 Galectin Therapeutics Plaque Psoriasis Treatment Medications Product Model Numbers, Pictures, Descriptions and Specifications 11.13.5 Galectin Therapeutics Recent Developments 11.14 Cellceutix 11.14.1 Cellceutix Company Information 11.14.2 Cellceutix Overview 11.14.3 Cellceutix Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2019-2024) 11.14.4 Cellceutix Plaque Psoriasis Treatment Medications Product Model Numbers, Pictures, Descriptions and Specifications 11.14.5 Cellceutix Recent Developments 11.15 Bayer 11.15.1 Bayer Company Information 11.15.2 Bayer Overview 11.15.3 Bayer Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2019-2024) 11.15.4 Bayer Plaque Psoriasis Treatment Medications Product Model Numbers, Pictures, Descriptions and Specifications 11.15.5 Bayer Recent Developments 11.16 Organon 11.16.1 Organon Company Information 11.16.2 Organon Overview 11.16.3 Organon Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2019-2024) 11.16.4 Organon Plaque Psoriasis Treatment Medications Product Model Numbers, Pictures, Descriptions and Specifications 11.16.5 Organon Recent Developments 11.17 UCB 11.17.1 UCB Company Information 11.17.2 UCB Overview 11.17.3 UCB Plaque Psoriasis Treatment Medications Sales, Price, Revenue and Gross Margin (2019-2024) 11.17.4 UCB Plaque Psoriasis Treatment Medications Product Model Numbers, Pictures, Descriptions and Specifications 11.17.5 UCB Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Plaque Psoriasis Treatment Medications Industry Chain Analysis 12.2 Plaque Psoriasis Treatment Medications Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Plaque Psoriasis Treatment Medications Production Mode & Process 12.4 Plaque Psoriasis Treatment Medications Sales and Marketing 12.4.1 Plaque Psoriasis Treatment Medications Sales Channels 12.4.2 Plaque Psoriasis Treatment Medications Distributors 12.5 Plaque Psoriasis Treatment Medications Customers 13 Plaque Psoriasis Treatment Medications Market Dynamics 13.1 Plaque Psoriasis Treatment Medications Industry Trends 13.2 Plaque Psoriasis Treatment Medications Market Drivers 13.3 Plaque Psoriasis Treatment Medications Market Challenges 13.4 Plaque Psoriasis Treatment Medications Market Restraints 14 Key Findings in the Global Plaque Psoriasis Treatment Medications Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 15.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Author Details 15.3 Disclaimer